Perspective Therapeutics (CATX) Share-based Compensation (2016 - 2026)
Perspective Therapeutics' Share-based Compensation history spans 17 years, with the latest figure at $2.6 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 21.69% to $2.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.4 million, a 40.67% increase, with the full-year FY2025 number at $9.0 million, up 71.73% from a year prior.
- Share-based Compensation hit $2.6 million in Q1 2026 for Perspective Therapeutics, up from $2.3 million in the prior quarter.
- Over the last five years, Share-based Compensation for CATX hit a ceiling of $2.6 million in Q1 2026 and a floor of $154000.0 in Q2 2022.
- Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.0 million in 2023.
- Biggest five-year swings in Share-based Compensation: soared 771.34% in 2023 and later plummeted 54.53% in 2024.
- Tracing CATX's Share-based Compensation over 5 years: stood at $496000.0 in 2022, then surged by 39.72% to $693000.0 in 2023, then skyrocketed by 197.26% to $2.1 million in 2024, then grew by 12.09% to $2.3 million in 2025, then increased by 10.57% to $2.6 million in 2026.
- Business Quant data shows Share-based Compensation for CATX at $2.6 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.